Patents Assigned to Barbeau Pharma, Inc.
  • Patent number: 7220858
    Abstract: The present invention relates to both a novel method of preparing hydralazine hydrochloride and to a novel method of preparing hydrazine derivatives of compounds containing a pyridazine ring, including, for example, pyridazines, phthalazines and other compounds containing the pyridazine ring.
    Type: Grant
    Filed: December 23, 2003
    Date of Patent: May 22, 2007
    Assignee: Barbeau Pharma, Inc.
    Inventor: Deanna J. Nelson
  • Patent number: 6825196
    Abstract: A method of improving the stability of a hydralazine composition during manufacturing or storage comprising coupling an N-protecting group with hydralazine to produce the compound having the formula: or a compound having the formula: where R1 and R2 are independently H, branched or straight chain alkyl having from 1 to about 7 carbon atoms, substituted or unsubstituted aryl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aralkyl, substituted or unsubstituted alkylcycloalkyl, lower alkenyl or R1 and R2 together form part of a substituted or unsubstituted cycloalkyl having from about 4 of about 7 carbon atoms; where R3 is a branched or straight chain alkyl having from 1 to about 7 carbon atoms, substituted or unsubstituted aryl, substituted or unsubstituted aralkyl, substituted or unsubstituted cycloalkyl, aralkyl, substituted or unsubstituted alkylcycloalkyl or a group having the formula (CH2)nCOOH where n is from 1 to about 7.
    Type: Grant
    Filed: March 5, 2002
    Date of Patent: November 30, 2004
    Assignee: Barbeau Pharma, Inc.
    Inventor: Donald L. Barbeau